Indeed, the most consistent clinical features of the SLC6A1-NDD carriers are ID varying from mild to severe, behavioral and attention deficit hyperactivity disorders, and developmental delay that have been reported in almost all patients. Here, SLC6A1 is linked to Global developmental delay.